Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Iclusig
Pharma
Novo, Novartis, Merck KGaA, Kyowa Kirin—Fierce Pharma Asia
Three pharma companies plan manufacturing expansions. Kyowa Kirin's gene therapy set a new pricing record. BeiGene won an FDA nod for its PD-1 drug.
Angus Liu
Mar 22, 2024 8:45am
Takeda's Iclusig wins first-line FDA nod to treat Ph+ALL
Mar 19, 2024 3:22pm
Takeda, Biogen, Astellas—Fierce Pharma Asia
Feb 17, 2023 8:50am
Takeda's Iclusig tops Novartis' Gleevec decisively in Ph+ALL
Feb 14, 2023 5:00pm
BioNTech, Astellas, Daiichi—Fierce Pharma Asia
Nov 18, 2022 10:11am
In Ph+ALL trial, Takeda's Iclusig outdoes Novartis' Gleevec
Nov 17, 2022 10:27am
